Thursday, October 29, 2020 4:37:06 PM
We have System orders which have reached the quoting phase in 3 Hospital Networks:
PCT LTD Provides Update on US Healthcare-related Activities
Little River, South Carolina — (August 5, 2020) – PCT LTD (OTC Pink: PCTL) is continuing its rapid expansion into the US Healthcare market with installations and targeted activities in multiple US Healthcare facilities nation-wide. PCTL, owner of the patented Annihilyzer® Infection Control System is continuing its
accelerated growth path with additional targeting and installation of systems in the US Healthcare market.
Following up on an earlier release, a system installation was performed for an existing hospital client in NYC through PCTL’s primary healthcare distributor, ACE Janitorial Services. This installation was completed in mid-June, the last of three scheduled installations mentioned in an
April 14th press release. The other two installations mentioned in the same announcement were completed and mentioned in a release on May 8th of this year.
Additional and ongoing activities in the US Healthcare market include, but are not limited to:
Installation of 5 additional systems with an existing NYC Hospital client.
Pending final approval for an additional installation of two systems at a third, existing NYC Hospital client.
In the quoting phase, an additional system order is pending approval for a large hospital network in upstate New York.
In the quoting phase, an additional system order is pending approval for a large hospital network in Connecticut
In the quoting phase, an additional system order is pending approval for a large hospital network in Tennessee.
System orders which have reached the quoting phase, barring any unforeseen restrictions or difficulties, should receive final approval and be installed within 30-60 days. Existing healthcare clients awaiting final approval should see installations commence within 30-60 days.
“The quoting phase can be a necessarily lengthy process at times,” explains Darryl Patterson, PCTL’s Director of Healthcare. “At this stage, multiple parties within a hospital organization need to give their final approval before we can move forward. Once approved, we can schedule
installations. “
Over the last several months, the company had shifted their focus towards fluid production and distribution due to increased demand brought on by the ongoing COVID-19 pandemic, coupled with travel restrictions. The company’s fluid production strength and sales remain strong and on
pace for record growth in 2020. Healthcare facility installations are a central focus of the company’s long-term growth plan.
“The pandemic had understandably caused disruption to on site outreach as well as installations,” says PCTL CEO Gary Grieco. “With more states relaxing travel restrictions, we can continue moving forward at healthy pace. Interest is as high as ever and we could not be happier to have the opportunity to continue our healthcare expansion efforts. We expect to continue to market and install systems in the United States at a steady pace through the end of the year.”
Recent PCTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 02:05:09 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/18/2023 07:06:52 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/13/2023 04:32:57 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM